Global Insulin Delivery Devices Market 2021

Publication ID:

NAV0518011

Publication Date:

May 11, 2018

Pages:

116

Countries:

Global [1]

Global Insulin delivery devices market faced various changes from past decades to current period. The industry is moving towards more sophisticated products like automated insulin pumps & patches as well as insulin inhalers. The industry is doing well and is expected to grow at a CAGR of 7.19% over the next five years. The growth will be largely due to the increase in user base for insulin delivery. The number of people being diagnosed with diabetes is increasing day by day and it will continue to increase over the next decade as well. This will surely take the demand for insulin delivery device higher and it’s up to the players in the industry, to develop products according to the demand.

Global Insulin delivery devices market is expected to grow at a CAGR of 7.19% by 2021.

This sector offers huge opportunity for firms to grow in future as there is a consistent increase in the patient base. Coupled with that, people are more than willing to use newer products which will be much more convenient to use and safer to use than insulin syringes. Despite, the high cost of such devices, people are willing to try for it and also the insurance company should be covering it under their scheme.

Another factor in the industry is the safety and security of the devices. There have been product recalls of large scale by the top players in the industry. This has put a question mark on the quality of the product that are being sent into the market. The problem is that the technologies are still being developed and yet to be perfected. Like Afrezza, an inhaled insulin device is yet to hit the mark in terms of market share. Its predecessor, Exubera was thought to be causing lung cancer and was removed from the shelf.

Overall the industry will continue to grow. As with any healthcare sector, this industry is also immune to global economic changes. It’s a mandatory device for anyone with diabetes, only they have the choice to change the type of device. Sometimes, the insurance companies don’t support one device, hence people have to change from that type to another. Also, cost is a factor, many device are of high cost like automated pumps, so the insurance companies doesn’t support it completely. Those patients have to go back to insulin syringes for delivery of insulin. Hence, it is of utmost importance for all stakeholders, that they continue to develop new products, which is cost friendly as well.

Scope of the Global Insulin Delivery Devices Market 2021 Report

This report provides a detailed view of Global Insulin Delivery Devices market scenario.
This report identifies the need for focusing on Insulin Delivery Devices Market
This report provides detailed information on Global Insulin Delivery Devices market with growth forecasts up to 2021.
This report also focuses on developing a better understanding of the current state of the Insulin Delivery Devices Technology.
This study also identifies various policies related to Global Insulin Delivery Devices market.
The report identifies the growth drivers and inhibitors for the global Insulin Delivery Devices market.
This report profiles 8 global players related to the Insulin Delivery Devices market.
This report provides detailed comparison chart of types of devices available in global Insulin Delivery Devices market.
This report provides detailed competitive landscape of Global Insulin Delivery Devices market.
This report identifies major challenges faced by new players in the Global Insulin Delivery Devices market.
The report identifies the key risks associated with the Global Insulin Delivery Devices Market.
This report provides future trends for the global Insulin Delivery Devices market.
This report also provides recommendations for policy makers.

1. Executive Summary

Scope of the Global Insulin Delivery Devices Market 2021 Report

Research Methodology

2. Need for Insulin Delivery Devices Market

3. Global Insulin Delivery Devices Market- Overview

3.1 Insulin Delivery Devices Evolution

3.2 Insulin Delivery Devices Value Chain

4. Market Segments & Forecasts for Global Insulin Delivery Devices Market

4.1 Overall Forecast for Global Insulin Delivery Devices Market till 2021

4.2 Insulin delivery devices Industry Forecast by Product Type

4.3 Insulin Delivery Devices Market Forecast Geography Wise

5.Growth Drivers & Inhibitors for Global Insulin Delivery Devices market

5.1 Growth Drivers

5.2 Growth Inhibitors

6.Risk Associated with Global Insulin Delivery Devices Market

6.1 Credit Risk

6.2 Policy Risk (Government)

6.3 Technical Risk

7. Profile of Key Players in Global Insulin Delivery Devices Market

7.1 Medtronic PLC

7.1.1 Company Profile

7.1.2 Medtronic in Insulin Delivery Devices Value Chain

7.1.3 Financial Performance of Medtronic PLC

7.1.4 Business Strategy

7.1.4.1 Product Level Business Strategy

7.1.4.2 Service Level Business Strategy

7.1.5 SWOT Analysis for Medtronic PLC

7.1.6 Key Customers

7.2 Eli Lilly and Company

7.2.1 Company Profile

7.2.2 Eli Lilly and company in Insulin Delivery Devices Value Chain

7.2.3 Financial Performance of Eli Lilly and Company

7.2.4 Business Strategy

7.2.4.1 Product Level Business Strategy

7.2.4.2 Service Level Business Strategy

7.2.5 SWOT Analysis for Eli Lilly and Company

7.2.6 Key Customers

7.3 Becton Dickinson and Company

7.3.1 Company Profile

7.3.2 Becton Dickinson in Insulin Delivery Devices Value Chain

7.3.3 Financial Performance of Becton Dickinson

7.3.4 Business Strategy

7.7.4.1 Product Level Business Strategy

7.3.4.2 Service Level Business Strategy

7.3.5 SWOT Analysis for Becton Dickinson

7.3.6 Key Customers

7.4 Novo Nordisk A/S

7.4.1. Company Profile

7.4.2 Novo Nordisk in Global Insulin Delivery Devices Value Chain

7.4.3 Financial Performance of Novo Nordisk

7.4.4 Business Strategy

7.4.4.1 Product Level Business Strategy

7.4.4.2 Service Level Business Strategy

7.4.5 SWOT Analysis for Novo Nordisk

7.4.6 Key Customers

7.5 Johnson & Johnson

7.5.1 Company Profile

7.5.2 Johnson & Johnson in Insulin Delivery Devices Value Chain

7.5.3 Financial Performance of Johnson & Johnson

7.5.4 Business Strategy

7.5.4.1 Product Level Business Strategy

7.5.4.2 Service Level Business Strategy

7.5.5 SWOT Analysis for Johnson & Johnson

7.5.6 Key Customers

7.6 Sanofi

7.6.1 Company Profile

7.6.2 Sanofi in the global insulin delivery devices Value Chain

7.6.3 Financial Performance of Sanofi

7.6.4 Business Strategy

7.6.4.1 Product Level Business Strategy

7.6.4.2 Service Level Business Strategy

7.6.5 SWOT Analysis for Sanofi

7.6.6 Key Customers

7.7 B. Braun Melsungen AG

7.7.1 Company Profile

7.7.2 B. Braun in Insulin Delivery Devices Value Chain

7.7.3 Financial Performance of B. Braun

7.7.4 Business Strategy

7.7.4.1 Product Level Business Strategy

7.7.4.2 Service Level Business Strategy

7.7.5 SWOT Analysis for B. Braun

7.7.6 Key Customers

7.8 YPSOMED

7.8.1 Company Profile

7.8.2 YPSOMED in Global Insulin Delivery Devices Value Chain

7.8.3 Financial Performance of YPSOMED

7.8.4 Business Strategy

7.8.4.1 Product Level Business Strategy

7.8.4.2 Service Level Business Strategy

7.8.5 SWOT Analysis for YPSOMED

7.8.6 Key Customers

8. Competitive Landscape in Global Insulin Delivery Devices Market

8.1 Merger and Acquisition

8.2 Competitive Landscape

9. Global Industry Associations related to Insulin Delivery Devices Market

9.1 American Diabetes Association

9.2 Diabetic Association of India.

9.3 International Diabetes Federation

10. Analysis Models

10.1 PESTLE Analysis

10.2 Porter’s Five Forces

10.3 Swot Analysis

11. Challenges faced by New Players in Global Insulin Delivery devices market

12. Current & Future Trends in the Global Insulin Delivery Devices Market

13. CASE STUDY

14. Strategic Recommendations

14.1 For Policy Makers

14.2 For End users

14.3 For Service Providers

14.4 For Investors

List of Exhibits

Notes

List of Exhibits

Exhibit 3.2 Insulin Delivery Devices Value Chain

Exhibit 4.1 Insulin Delivery Devices Market Forecast till 2021

Exhibit 4.2.1 Insulin Delivery Industry Forecast by Product Type

Exhibit 4.2.2 Insulin Delivery Industry till 2021 CAGR

Exhibit 4.2.3 Insulin Syringes Growth Estimate till 2021

Exhibit 4.2.4 Insulin Pump Growth Estimate till 2021

Exhibit 4.2.5 Insulin Pen Growth Estimate till 2021

Exhibit 4.2.6 Insulin Jet Injectors Growth Estimate till 2021

Exhibit 4.2.7 Insulin Patches Growth Estimate till 2021

Exhibit 4.3.1 Insulin Delivery Market Forecast Geography wise

Exhibit 4.3.2 Geography wise CAGR

Exhibit 4.3.3 North American Market Growth Forecast till 2021

Exhibit 4.3.4 South American Market Growth Forecast till 2021

Exhibit 4.3.5 Middle East & Africa Market Growth Forecast till 2021

Exhibit 4.3.6 European Market Growth Forecast till 2021

Exhibit 4.3.7 Asia Pacific Market Growth Forecast till 2021

Exhibit 5.1 Growth Drivers & Inhibitors in Global Insulin Delivery market.

Exhibit 7.1.1 Company Profile – Medtronic PLC

Exhibit 7.1.2 Contact Details – Medtronic PLC

Exhibit 7.1.3 Medtronic PLC in Global Insulin Delivery Value Chain

Exhibit 7.1.4 Medtronic PLC Revenue from 2011-12 to 2015-16

Exhibit 7.1.5 Year-wise MEDTRONIC PLC Revenue Growth from 2011-12 to 2015-16

Exhibit 7.1.6 Estimated MEDTRONIC PLC in Revenue from 2016-17 to 2020-21

Exhibit 7.1.7 Estimated Year-wise MEDTRONIC Revenue Growth from 2016-17 to 2020-21

Exhibit 7.1.8 Major Products and Services of Medtronic PLC

Exhibit 7.1.9 SWOT Analysis of MEDTRONIC PLC

Exhibit 7.1.10 List of Key Customers of MEDTRONIC PLC

Exhibit 7.2.1 Company Profile – Eli Lilly

Exhibit 7.2.2 Contact Details – Eli Lilly

Exhibit 7.2.3 Eli Lilly in Global Insulin Delivery Devices Value Chain

Exhibit 7.2.4 Eli Lilly Revenue from 2011-12 to 2015-16

Exhibit 7.2.5 Year-wise Eli Lilly Revenue Growth from 2011-12 to 2015-16

Exhibit 7.2.6 Estimated Eli Lilly in Revenue from 2016-17 to 2020-21

Exhibit 7.2.7 Estimated Year-wise Eli Lilly Revenue Growth from 2016-17 to 2020-21

Exhibit 7.2.8 Major Products and Services of Eli Lilly

Exhibit 7.2.9 SWOT Analysis of Eli Lilly

Exhibit 7.2.10 List of Key Customers of Eli Lilly

Exhibit 7.3.1 Company Profile – BECTON DICKINSON

Exhibit 7.3.2 Contact Details – BECTON DICKINSON

Exhibit 7.3.3 BECTON DICKINSON in Global Insulin Delivery Value Chain

Exhibit 7.3.4 BECTON DICKINSON Revenue from 2011-12 to 2015-16

Exhibit 7.3.5 Year-wise BECTON DICKINSON Revenue Growth from 2011-12 to 2015-16

Exhibit 7.3.6 Estimated BECTON DICKINSON Revenue from 2016-17 to 2020-21

Exhibit 7.3.7 Estimated Year-wise BD Revenue Growth from 2016-17 to 2020-21

Exhibit 7.3.8 Major Products and Services of BECTON DICKINSON

Exhibit 7.3.9 SWOT Analysis of BECTON DICKINSON

Exhibit 7.4.1 Company Profile – NOVO NORDISK

Exhibit 7.4.2 Contact Details – NOVO NORDISK

Exhibit 7.4.3 NOVO NORDISK in Global Insulin Delivery Value Chain

Exhibit 7.4.4 NOVO NORDISK Revenue from 2011-12 to 2015-16

Exhibit 7.4.5 Year-wise NOVO NORDISK Revenue Growth from 2011-12 to 2015-16

Exhibit 7.4.6 Estimated NOVO NORDISK Revenue from 2016-17 to 2020-21

Exhibit 7.4.7 Estimated Year-wise NOVO NORDISK Revenue Growth from 2016-17- 2020-21

Exhibit 7.4.8 Major Products and Services of NOVO NORDISK

Exhibit 7.4.9 SWOT Analysis of NOVO NORDISK

Exhibit 7.4.10 List of Key Customers of NOVO NORDISK

Exhibit 7.5.1 Company Profile – J&J

Exhibit 7.5.2 Contact Details – J&J

Exhibit 7.5.3 J&J in Global Insulin Delivery Value Chain

Exhibit 7.5.4 J&J Revenue from 2011-12 to 2015-16

Exhibit 7.5.5 Year-wise J&J Revenue Growth from 2011-12 to 2015-16

Exhibit 7.5.6 Estimated J&J in Revenue from 2016-17 to 2020-21

Exhibit 7.5.7 Estimated Year-wise J&J Revenue Growth from 2016-17 to 2020-21

Exhibit 7.5.8 Major Products and Services of J&J

Exhibit 7.5.9 SWOT Analysis of J&J

Exhibit 7.5.10 List of Key Customers of J&J

Exhibit 7.6.1 Company Profile – SANOFI

Exhibit 7.6.2 Contact Details – SANOFI

Exhibit 7.6.3 SANOFI in Global Insulin Delivery Value Chain

Exhibit 7.6.4 SANOFI Revenue from 2011-12 to 2015-16

Exhibit 7.6.5 Year-wise SANOFI Revenue Growth from 2011-12 to 2015-16

Exhibit 7.6.6 Estimated SANOFI in Revenue from 2016-17 to 2020-21

Exhibit 7.6.7 Estimated Year-wise SANOFI Revenue Growth from 2016-17 to 2020-21

Exhibit 7.6.8 Major Products and Services of SANOFI

Exhibit 7.6.9 SWOT Analysis of SANOFI

Exhibit 7.6.10 List of Key Customers of SANOFI

Exhibit 7.7.1 Company Profile – B. BRAUN

Exhibit 7.7.2 Contact Details – B. BRAUN

Exhibit 7.7.3 B. BRAUN in Global Insulin Delivery Value Chain

Exhibit 7.7.4 B. BRAUN Revenue from 2011-12 to 2015-16

Exhibit 7.7.5 Year-wise B. BRAUN Revenue Growth from 2011-12 to 2015-16

Exhibit 7.7.6 Estimated B. BRAUN in Revenue from 2016-17 to 2020-21

Exhibit 7.7.7 Estimated Year-wise B. BRAUN Revenue Growth from 2015-16 - 2020-21

Exhibit 7.7.8 Major Products and Services of B. BRAUN

Exhibit 7.7.9 SWOT Analysis of B. BRAUN

Exhibit 7.8.1 Company Profile – YPSOMED

Exhibit 7.8.2 Contact Details – YPSOMED

Exhibit 7.8.3 YPSOMED in Global Insulin Delivery Value Chain

Exhibit 7.8.4 YPSOMED Revenue from 2011-12 to 2015-16

Exhibit 7.8.5 Year-wise YPSOMED Revenue Growth from 2011-12 to 2015-16

Exhibit 7.8.6 Estimated YPSOMED in Revenue from 2016-17 to 2020-21

Exhibit 7.8.7 Estimated Year-wise YPSOMED Revenue Growth from 2016-17 to 2020-21

Exhibit 7.8.8 Major Products and Services of YPSOMED

Exhibit 7.8.9 SWOT Analysis of YPSOMED

Exhibit 7.8.10 List of Key Customers of YPSOMED

Medtronic PLC
Eli Lilly and Company
Becton Dickinson and Company
Novo Nordisk A/S
Johnson & Johnson
Sanofi
B. Braun Melsungen AG
YPSOMED

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Enterprise license fee.

Enterprise License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.